The author wrote that personalised medicine could transform prevention, diagnosis and treatment, but said its breakthroughs would matter only if they reached patients. In a message to a conference on personalised medicine in Ireland, the author said EU pharmaceutical reform and the Biotech Act could support innovation and access. https://t.co/W7FMPjG9Gn #PersonalisedMedicine #Innovation #Healthcare #IE #EU
🇪🇺 produces 21% of the world’s leading biotech publications, but our share of global clinical trials fell from 18% to 9%. The #BiotechAct is our answer: faster trials, more investment, clearer rules, stronger incentives for 🇪🇺 manufacturing & better use of health data and AI. #BiotechAct #ClinicalTrials #HealthData #EU
Vandaag sprak ik in @de_Markt_ op VRT over de Europese #BiotechAct, waarvoor ik rapporteur ben in het Europees Parlement. Europa heeft topwetenschap, sterke onderzoekers en innovatieve biotechbedrijven. Maar we verliezen terrein aan de VS en China. Dat moeten we keren. Europese https://t.co/OHN5to4EvC #BiotechAct #EU #Innovatie #EU #US #CN
This is where data, AI, diagnostics & medical devices can deliver practical results. With the #SafeHeartsPlan, #BiotechAct, medical devices reform & the European Health Data Space, 🇪🇺 is putting prevention and innovation at the centre. Aim: act earlier, detect sooner, save lives. #HealthInnovation #MedicalDevices #DataDrivenHealthcare #EU
Alzheimer’s affects memory, identity & independence with a huge impact on patients, families & caregivers. In my message at MindShift in 🇮🇹, I underlined 🇪🇺 support for prevention, diagnosis & care from brain health research to the #SafeHeartsPlan, #medicaldevices & #BiotechAct. https://t.co/fPIE8Q5LKT #Alzheimers #BrainHealth #Caregiving #IT #EU
Generics and biosimilars are key to keeping medicines accessible & health systems sustainable. At @medicinesforEU Conference in Athens, I highlighted how #pharmareform, #CriticalMedicinesAct & #BiotechAct will strengthen affordability, supply resilience and 🇪🇺medicine security. https://t.co/cJW6Qhq6C3 #pharmareform #CriticalMedicinesAct #BiotechAct #EU
This sector also generates a huge share of health data - unlocking further innovation in healthcare. The medical devices reform and the #BiotechAct need to be in place as soon as possible to secure what European citizens deserve: the best diagnostics and therapies. #HealthData #MedicalDevices #BiotechAct #EU
This is why the #BiotechAct is so needed: Europe’s health system resilience and competitiveness depend on it. #BiotechAct #HealthSystem #EuropeCompetitiveness #EU
This is exactly the kind of innovation Europe needs and the kind we must help remain, develop and scale up in Europe. That is the very purpose of the #BiotechAct. ⏩️We need to adopt it quickly. #BiotechAct #Innovation #Europe #EU
Today’s debate shows more than ever that we need to move quickly on the Health Package. With the #BiotechAct, medical devices reform and #SafeHeartsPlan, we can build a stronger, more resilient health ecosystem that delivers for patients. #BiotechAct #SafeHeartsPlan #HealthPackage #Therearenospecificcountriesmentionedinthetweetyouprovided.Therefore #theresultisanemptystring.
Now, with the #BiotechAct, medical devices reform and the pharmaceutical package, we want to accelerate innovation and improve access to new diagnostics and therapies for rare and complex conditions. ➡️ Rare should never mean invisible. #RareDiseases #BiotechInnovation #HealthcareAccess #Nospecificcountrycodesarementionedinthetweet.
